301 related articles for article (PubMed ID: 30467800)
1. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic
Tasaki Y; Inoue N; Shimizu M; Sugimoto N; Ishikawa S; Mizuta M; Yokoyama T; Kuroda M; Ohta K; Yachie A; Wada T
Ren Fail; 2021 Dec; 43(1):382-387. PubMed ID: 33641616
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.
Shimizu M; Kuroda M; Sakashita N; Konishi M; Kaneda H; Igarashi N; Yamahana J; Taneichi H; Kanegane H; Ito M; Saito S; Ohta K; Taniguchi T; Furuichi K; Wada T; Nakagawa M; Yokoyama H; Yachie A
Cytokine; 2012 Dec; 60(3):694-700. PubMed ID: 22929411
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
Shimizu M; Inoue N; Kuroda M; Irabu H; Takakura M; Kaneda H; Sugimoto N; Ohta K; Yachie A
Clin Exp Nephrol; 2017 Dec; 21(6):1083-1087. PubMed ID: 28283851
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Shimizu M; Inoue N; Kuroda M; Mizuta M; Sugimoto N; Kaneda H; Ohta K; Yachie A
Clin Exp Nephrol; 2017 Feb; 21(1):76-82. PubMed ID: 26945868
[TBL] [Abstract][Full Text] [Related]
6. Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome.
Kuroda M; Shimizu M; Inoue N; Ikeno I; Nakagawa H; Yokoi A; Niida Y; Konishi M; Kaneda H; Igarashi N; Yamahana J; Taneichi H; Kanegane H; Ito M; Saito S; Furuichi K; Wada T; Nakagawa M; Yokoyama H; Yachie A
Neurochem Int; 2015; 85-86():24-30. PubMed ID: 25895963
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic functions and diagnostic utility of cytokines/chemokines in EHEC-HUS.
Shimizu M
Pediatr Int; 2020 Mar; 62(3):308-315. PubMed ID: 31742829
[TBL] [Abstract][Full Text] [Related]
8. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
[TBL] [Abstract][Full Text] [Related]
9. Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.
Shimizu M; Kuroda M; Inoue N; Konishi M; Igarashi N; Taneichi H; Kanegane H; Ito M; Saito S; Yachie A
Cytokine; 2014 Mar; 66(1):1-6. PubMed ID: 24548418
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
[TBL] [Abstract][Full Text] [Related]
12. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.
Orth D; Khan AB; Naim A; Grif K; Brockmeyer J; Karch H; Joannidis M; Clark SJ; Day AJ; Fidanzi S; Stoiber H; Dierich MP; Zimmerhackl LB; Würzner R
J Immunol; 2009 May; 182(10):6394-400. PubMed ID: 19414792
[TBL] [Abstract][Full Text] [Related]
13. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
[TBL] [Abstract][Full Text] [Related]
14. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
Zimmerhackl LB; Rosales A; Hofer J; Riedl M; Jungraithmayr T; Mellmann A; Bielaszewska M; Karch H
Semin Thromb Hemost; 2010 Sep; 36(6):586-93. PubMed ID: 20865635
[TBL] [Abstract][Full Text] [Related]
15. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.
Reising A; Hafer C; Hiss M; Kielstein JT; Menne J; Gueler F; Beneke J; Linnenweber-Held S; Haller H; Einecke G
Int Urol Nephrol; 2016 Apr; 48(4):561-70. PubMed ID: 26759326
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.
Ehrlenbach S; Rosales A; Posch W; Wilflingseder D; Hermann M; Brockmeyer J; Karch H; Satchell SC; Würzner R; Orth-Höller D
Infect Immun; 2013 Aug; 81(8):2678-85. PubMed ID: 23690395
[TBL] [Abstract][Full Text] [Related]
18. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
Shiraishi M; Ichiyama T; Matsushige T; Iwaki T; Iyoda K; Fukuda K; Makata H; Matsubara T; Furukawa S
J Neuroimmunol; 2008 May; 196(1-2):147-52. PubMed ID: 18410971
[TBL] [Abstract][Full Text] [Related]
19. Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome.
Orth-Höller D; Würzner R
Semin Thromb Hemost; 2014 Jun; 40(4):503-7. PubMed ID: 24799304
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Deficits Found in a Pro-inflammatory State are Independent of ERK1/2 Signaling in the Murine Brain Hippocampus Treated with Shiga Toxin 2 from Enterohemorrhagic Escherichia coli.
Berdasco C; Pinto A; Blake MG; Correa F; Carbajosa NAL; Celi AB; Geoghegan PA; Cangelosi A; Nuñez M; Gironacci MM; Goldstein J
Cell Mol Neurobiol; 2023 Jul; 43(5):2203-2217. PubMed ID: 36227397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
